evidence: Compared to placebo, patients in the olanzapine group experienced greater improvement in the primary outcome measure, MADRS total score (−14.9 vs. −10.7; p = .01).
intervention: olanzapine
comparator: placebo
outcome: improvement in the primary outcome measure, MADRS total score